Sat.Feb 20, 2021 - Fri.Feb 26, 2021

article thumbnail

Healthcare’s digital transformation began within weeks of pandemic – report

pharmaphorum

Healthcare organisations that have been traditionally slow to adopt new technology produced a response to the pandemic that was almost in line with less regulated industries, according to a new report. Findings of research from the cloud communications platform Twilio based on 2,500 enterprise decision makers, including 117 healthcare organisations, showed it took 36 days on average to accelerate a digital transformation strategy.

article thumbnail

BEST haemorrhoids treatment UK [Reviewed]

Druggist

Haemorrhoids (haemorrhoids), also known as piles, is a common condition that causes rectal symptoms. Today I will review the best haemorrhoids treatment in the UK. I will discuss the best haemorrhoids treatment over the counter in the UK (part one) and prescription-only options to treat piles (part 2). . Summary: . What are haemorrhoids? . Symptoms of haemorrhoids.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Trust, transparency aided COVID-19 vaccine partnership: Praxis

Outsourcing Pharma

A leader from Praxis explains how the firm worked with Moderna on patient recruitment strategy and other solutions in the road to launching a vaccine.

article thumbnail

NHS to open mental health support hubs dedicated to staff

Pharma Times

Services will be offered to staff who have been affected by the COVID-19 pandemic

55
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

A history of Johnson & Johnson

pharmaphorum

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a strong pharmaceutical backbone that has emerged over the company’s long and varied history.

Vaccines 126
article thumbnail

New Sales Directors at Romaco in Cologne, Bologna and Karlsruhe

Pharma Mirror

Borja Guerra has been appointed new Sales & Service Director of Romaco Kilian in Cologne. The Romaco facilities in Bologna and Karlsruhe likewise have new Sales Directors: Massimiliano Cesarini and Ralph Augenstein. Romaco Kilian GmbH in Cologne has acquired a new Sales & Service Director. As of February 2021, Borja Guerra is responsible not only for the Sales & Service department but also for product and project management at the manufacturer of tablet presses for the pharmaceutical

52

More Trending

article thumbnail

Parkinson’s UK creates Vivifi Biotech to research ‘promising’ experimental treatment

Pharma Times

Biotech company will be dedicated to accelerating development of potential treatment

54
article thumbnail

Common but not normal: It’s time to talk about maternal mental health

pharmaphorum

As part of our Patients Insights series, the founder and CEO of Motherhood Understood shares her experience of postpartum depression, talks about the power of peer support, and explains what the wider healthcare community could do to play their part. Within days of giving birth to her first child, Jen Schwartz’s fairy tale view of motherhood lay in tatters at the foot of the bed she found it impossible to leave.

Hospitals 122
article thumbnail

Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site

Pharma Mirror

SOMERSET, N.J. and GOSSELIES, BELGIUM — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based in Gosselies, Belgium, today announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of th

52
article thumbnail

ICON to acquire PRA Health Sciences in $12b deal

Outsourcing Pharma

The deal consolidates two significant players in the contract research organization arena, in a deal reportedly worth approximately $12b USD.

72
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

NHS England to trial at-home smear testing kits

Pharma Times

Over 31,000 women in London to be offered the at-home tests

53
article thumbnail

Why we need research into the mental health impact of a rare disease diagnosis

pharmaphorum

Rare diseases impact between 3.5%-5.9% of the world’s population. For Rare Disease Day, RBW Consulting’s Emma Thorp discusses why the consultancy is taking revenue earned from its rare disease clients and using it to fund research into the mental health impact of a rare disease diagnosis. Rare diseases are often chronic and life-threatening, and with a large percentage of cases presenting in young children, a diagnosis has a profound and unique impact on everyone affected.

Hospitals 117
article thumbnail

Reflections on Becoming a Virtual Company

McCreadie Group

February 2021 | Scott McCreadie, PharmD, MBA | Founder, President and CEO Not unlike for everyone else, 2020 was an eventful year for the McCreadie Group, and it changed a number of aspects of how we do business. I would like to reflect on one of the biggest changes we made: transitioning to a virtual company. The post Reflections on Becoming a Virtual Company appeared first on McCreadie Group Blog.

52
article thumbnail

Patient-centric approach key to rare disease research: Centogene

Outsourcing Pharma

A leader from the genetics diagnostic solutions company explains how putting the patient first can make the difference in orphan drug development.

65
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Wayra, GE Healthcare launch accelerator programme for digital health start-ups

Pharma Times

Edison Accelerator to support start-ups to develop AI applications for healthcare

51
article thumbnail

Sanofi’s immunotherapy Libtayo gets FDA not in first line lung cancer

pharmaphorum

Sanofi’s cancer immunotherapy Libtayo (cemiplimab) has a third US indication after the FDA approved it for certain untreated lung cancer patients. The approval in first-line lung cancer, in non-small cell lung cancer patients whose tumours have high PD-L1 expression brings the drug into competition with Merck & Co’s Keytruda (pembrolizumab), which has become the go-to therapy in this disease.

FDA 116
article thumbnail

Rytary (Carbidopa-Levodopa ER) in Parkinson’s Disease

Med Ed 101

Parkinson’s disease (PD) has long presented challenges in medication delivery. A staple in more advanced disease control, carbidopa-levodopa requires multiple daily dosing with supratherapeutic levels leading to dyskinesias and subtherapeutic concentrations leading to troublesome “off” time. Sinemet (carbidopa-levodopa), Sinemet Controlled-Release (CR), and their respective generic equivalents have been used in PD for decades, but leave […].

article thumbnail

Developing vaccines and therapeutics for virus variants: FDA releases new guidance

Outsourcing Pharma

The US Food and Drug Administration (FDA) has issued guidance for companies developing vaccines, diagnostics and therapeutics against new variants of SARS-CoV-2.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Ocugen’s inherited retinal disease gene therapy OCU400 wins orphan status

Pharma Times

Orphan designation granted for the treatment of retinitis pigmentosa and Leber Congenital amaurosis

51
article thumbnail

Building a better future for people with rare diseases in all four UK nations

pharmaphorum

How has rare disease care changed over the last few years? And what might we expect from the next five? We attended the Rare Disease Day Virtual Parliamentary Event to find out. The rare disease community has a golden opportunity to transform the way care is delivered across all four UK nations – that’s according to speakers at a parliamentary reception held to mark 2021’s Rare Disease Day.

article thumbnail

Doxepin Pharmacodynamics: Indication or Adverse Effect?

Med Ed 101

Doxepin is a tricyclic antidepressant first approved for the treatment of depression in 1969 by the FDA. Tricyclic antidepressants are famous for their anticholinergic adverse effects including sedation and have been replaced by better-tolerated medications as first-line agents for depression. Doxepin pharmacodynamics helps determine what indications it may be beneficial for.

FDA 40
article thumbnail

Direct data capture a 'game changer' for trials: Clinical Ink

Outsourcing Pharma

An executive from the clinical trial technology provider will share how direct data capture can save time, avoid errors and improve the patient experience.

59
article thumbnail

UK sees a 20% growth in the number of advanced therapy trials, report finds

Pharma Times

Cell and Gene Therapy Catapult report also found a surge in the number of commercially sponsored trials

50
article thumbnail

Altimmune begins trial of nasal vaccine for COVID-19

pharmaphorum

Pfizer/BioNTech’s mRNA vaccine against COVID is a technical marvel – but the ultra-cool temperatures required for storage and stability has been tricky to handle. Maryland, US-based company Altimmune is among the biotechs and research labs trying to find more convenient alternatives and believes a nasal vaccine spray that is stable at room temperature could be the answer.

Vaccines 111
article thumbnail

Pharma: Clinical 2021 | April 7-9 | Virtual

Pharma Marketing Network

Clinical is under the microscope. As the world focuses its lens on pharma, the opportunity and pressure is there to found a new era of agile, patient-centric clinical trials. Long-standing barriers to innovation are falling, digital transformation is accelerating, and new cultures in collaboration, and patient-centricity are rapidly growing. The conversations that are re-shaping the future of clinical are happening as we speak, Reuters Events Clinical 2021 is the new meeting place for US and EU

52
article thumbnail

SCOPE 2021 to take on tough clinical trial challenges

Outsourcing Pharma

The annual event, moved to the virtual realm thanks to COVID-19, offers content on remote monitoring, drug development technology and other key topics.

56
article thumbnail

AZ withdraws Imfinzi indication in the US for advanced bladder cancer

Pharma Times

Decision made in consultation with the FDA following disappointing trial results

FDA 48
article thumbnail

Rare disease insights from the patient community

pharmaphorum

To help pharma companies understand what life is really like for patients with a rare disease, a new resource has been released to coincide with Rare Disease Day 2021. A series of stakeholder interviews have been collected in a new video from Bedrock Healthcare Communications and Origins Insights that explores the underappreciated challenges of living with a rare disease.

article thumbnail

Pharma Customer Engagement Europe | April 20-22, 2021 | Virtual

Pharma Marketing Network

As markets swell with digital content and HCPs become increasingly time-poor, your customer engagement strategy can no longer be driven by reach and frequency, but by the value added at every interaction and touchpoint. At Pharma Customer Engagement Europe (20-22 April, Virtual) leaders unite to develop hybrid field force models, measure true digital effectiveness, and optimize content to make holistic customer engagement the norm and surpass HCP needs.

52
article thumbnail

AstraZeneca joins with Care Access Research on COVID-19 antibody trial

Outsourcing Pharma

The pharma firm is partnering with the decentralized research organization on a Phase III trial testing a long-acting antibody combination treatment.

56
article thumbnail

PharmaTimes are excited to announce the launch of CROY 2021

Pharma Times

The prestigious Clinical Researcher of the Year – The Americas has now opened its doors for entry, continuing the successes of the 10th anniversary last year.

48
article thumbnail

UCB and Microsoft announce digital drug R&D tie-up

pharmaphorum

UCB and Microsoft have announced a multi-year strategic collaboration to advance the digitalisation of the Belgian pharma company and accelerate its research efforts. The companies have already been working together on the COVID Moonshot Project, which aimed to create an orally available antiviral to combat the SARS-CoV-2 coronavirus. UCB completed six months’ worth of computational screening and compound design in three days using the technology.

article thumbnail

Pharma USA 2021 | May 25 – June 4 | Virtual

Pharma Marketing Network

Look around – what do you see? Empowered patients, remote monitoring and care, platform technologies, personalized and preventative health, AI, machine learning and advanced analytics, virtual engagement, decentralized trials, telehealth, cell and gene therapy commercialization… the list goes on. Pharma is undergoing a period of unrivaled change.

40